| 前收市價 | 2.7500 |
| 開市 | 2.7500 |
| 買盤 | 2.7000 |
| 賣出價 | 3.1000 |
| 拍板 | 26.00 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 2.7500 - 2.7500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 11 |
Investor's Business DailyThe Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
ZacksWhy Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
InvestorPlace3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resurgence. Breakthroughs in personalized medicine and gene editing technologies are driving biotech forward. The global biotechnology market was valued at $1.0 trillion in 2022 and is projected to reach $3.6 trillion by 2032. Increasing demand for personalized medicine and advancements in genetic engin
